CD14 and triple-A syndrome: We recently reported that patients with AAA frequently have mild-to-moderate CKD and an expanded population of CD14+CD16+monocytes [18], which represent an intermediate subset among the ‘classical’ (CD14+CD16-) and ‘nonclassical’ (CD14dimCD16+) ones.